Journal Watch · Frontiers in Immunology · 2026
Interleukin-6 regulates the neutrophil response to diverse bacteria.
Together, these results demonstrate that IL-6 exerts concentration- and pathogen-dependent effects on neutrophil recruitment and migration, supporting a dual role for IL-6 as both pro-inflammatory and anti-inflammatory, with higher IL-6 concentrations resulting in a more anti-inflammatory neutrophil response.
TL;DR
Together, these results demonstrate that IL-6 exerts concentration- and pathogen-dependent effects on neutrophil recruitment and migration, supporting a dual role for IL-6 as both pro-inflammatory and anti-inflammatory, with higher IL-6 concentrations resulting in a more anti-inflammatory neutrophil response.
Key findings
- We found that increasing IL-6 concentration resulted in decreased VE-cadherin expression and that 100 ng/mL exogenous IL-6 resulted in lower ICAM-1 expression than 10 ng/mL exogenous IL-6 in an endothelium exposed to <i>P. aeruginosa</i>.
- Together, these results demonstrate that IL-6 exerts concentration- and pathogen-dependent effects on neutrophil recruitment and migration, supporting a dual role for IL-6 as both pro-inflammatory and anti-inflammatory, with higher IL-6 concentrations resulting in a more anti-inflammatory neutrophil response.
What they did
We found that a high exogenous IL-6 concentration (100 ng/mL) reduced neutrophil extravasation, migration speed, and displacement compared to conditions without exogenous IL-6. In contrast, a lower exogenous IL-6 concentration (10 ng/mL) produced pathogen-specific effects on neutrophil extravasation: exogenous IL-6 increased neutrophil extravasation in response to <i>Pseudomonas aeruginosa</i>, did not change in response to <i>Listeria monocytogenes</i>, and decreased in response to <i>Staphylococcus aureus</i> relative to controls. We then determined the potential endothelial cell contributions to these responses.
Full abstract (original)
Background: Neutrophils are critical mediators of the innate immune response, and their antimicrobial functions are tightly regulated by a myriad of cytokines. Interleukin-6 (IL-6) is known to be essential for an effective immune response; however, how varying IL-6 concentrations affect the neutrophil response remains poorly understood. Because IL-6 concentrations can vary greatly across different disease states, we investigated the concentration dependent effects of IL-6 on the neutrophil response to diverse bacterial pathogens using an infection-on-a-chip microfluidic device.
What they did: We found that a high exogenous IL-6 concentration (100 ng/mL) reduced neutrophil extravasation, migration speed, and displacement compared to conditions without exogenous IL-6. In contrast, a lower exogenous IL-6 concentration (10 ng/mL) produced pathogen-specific effects on neutrophil extravasation: exogenous IL-6 increased neutrophil extravasation in response to <i>Pseudomonas aeruginosa</i>, did not change in response to <i>Listeria monocytogenes</i>, and decreased in response to <i>Staphylococcus aureus</i> relative to controls. We then determined the potential endothelial cell contributions to these responses.
Results & conclusions: We found that increasing IL-6 concentration resulted in decreased VE-cadherin expression and that 100 ng/mL exogenous IL-6 resulted in lower ICAM-1 expression than 10 ng/mL exogenous IL-6 in an endothelium exposed to <i>P. aeruginosa</i>. Together, these results demonstrate that IL-6 exerts concentration- and pathogen-dependent effects on neutrophil recruitment and migration, supporting a dual role for IL-6 as both pro-inflammatory and anti-inflammatory, with higher IL-6 concentrations resulting in a more anti-inflammatory neutrophil response.
Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1783843 · PubMed 41822491.
Why it matters for pharma & biotech
- Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Frontiers in Immunology study find?
Together, these results demonstrate that IL-6 exerts concentration- and pathogen-dependent effects on neutrophil recruitment and migration, supporting a dual role for IL-6 as both pro-inflammatory and anti-inflammatory, with higher IL-6 concentrations resulting in a more anti-inflammatory neutrophil response.
What type of study is this?
It is a research study, published in Frontiers in Immunology in 2026. We found that a high exogenous IL-6 concentration (100 ng/mL) reduced neutrophil extravasation, migration speed, and displacement compared to conditions without exogenous IL-6.
Where can I read the original paper?
The original is at the publisher via DOI 10.3389/fimmu.2026.1783843. PubMed ID: 41822491. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/interleukin-6-regulates-the-neutrophil-response-to-diverse-bacteria-783843/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides